The Intercept

The Intercept @theintercept

Eli Lilly is one of the three companies that control the insulin industry. Last year, Eli Lilly collected over $2.4 billion in revenue from its insulin products, including the brand Humalog, with roughly $1.3 billion of that from U.S.-based sales. https://t.co/EFCmoMNJo4 — PolitiTweet.org

The Intercept @theintercept

On @intercepted, we go behind the Inflation Reduction Act to look at the dynamics driving inflation, scrutinize the solutions being pushed by fiscal hawks, and demystify the economic jargon being used to sideline worker interests in pursuit of profit. https://t.co/K8JUPmmkVC — PolitiTweet.org